Literature DB >> 22317761

Imaging tumor sensitivity to a bioreductive prodrug: two for the price of one!

J Martin Brown1.   

Abstract

Hypoxia is an important characteristic of many solid tumors and has a major negative effect on treatment response. A way to combat this effect is with drugs called "bioreductive prodrugs" or "hypoxic cytotoxins," which are metabolized under hypoxia to toxic species. However, the patients with hypoxic tumors need to be identified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22317761     DOI: 10.1158/1078-0432.CCR-11-3267

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  4 in total

Review 1.  Optimizing hypoxia detection and treatment strategies.

Authors:  Cameron J Koch; Sydney M Evans
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

2.  Enzymatic conversion of 6-nitroquinoline to the fluorophore 6-aminoquinoline selectively under hypoxic conditions.

Authors:  Anuruddha Rajapakse; Collette Linder; Ryan D Morrison; Ujjal Sarkar; Nathan D Leigh; Charles L Barnes; J Scott Daniels; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2013-04-02       Impact factor: 3.739

3.  Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery.

Authors:  Philip Penketh; Hugh Williamson; Krishnamurthy Shyam
Journal:  Curr Drug Deliv       Date:  2020       Impact factor: 2.565

Review 4.  Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.

Authors:  Roger M Phillips
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-25       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.